Select Medical Holdings (SEM) Financials

$16.51

$-0.02 (-0.12%)

As on 30-Jun-2026 16:03EDT

Market cap

$2,046 Mln

Revenue (TTM)

$5,521 Mln

P/E Ratio

15.4

P/B Ratio

1.2

Div. Yield

1.5 %

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Operating Revenue	5,521.13	5,452.83	5,187.11	6,664.06	6,333.54	6,204.52
Cost of Revenue	4,933.14	4,823.54	4,553.46	5,732.02	5,600.16	5,285.15
Gross Profit	588.00	629.30	633.64	932.04	733.38	919.37
Operating Expenses	266.15	294.72	365.33	377.17	330.09	205.59
Operating Profit (EBIT)	321.84	334.58	268.32	554.87	403.28	713.77
Other Income	--	--	--	--	26.41	46.58
Profit before Tax	258.66	272.75	174.77	382.36	260.58	629.72
Provision for Tax	55.08	58.22	44.78	82.63	62.55	129.77
Profit after Tax (Net Income)	133.53	146.22	214.04	243.49	158.99	402.23
Minority Interest	-70.04	-68.31	-82.67	-56.24	-39.03	97.72
Consolidated Profit	87.39	142.87	211.72	241.36	153.39	402.23

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Shareholder's Funds	1,756.02	1,705.58	1,681.36	1,288.30	1,121.92	1,109.98
Minority Interest	-70.04	--	--	--	234.64	215.92
Non-Current Liabilities	2,965.78	2,831.36	2,633.21	4,867.15	5,119.54	4,722.16
Current Liabilities	970.37	984.49	977.65	1,248.47	1,155.15	1,273.08
Total Liabilities	7,012.45	5,851.59	5,607.95	7,689.63	7,665.29	7,360.17

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Non-Current Assets	4,929.99	4,826.31	4,588.17	6,431.99	6,393.98	6,220.73
Current Assets	1,112.10	1,025.28	1,019.78	1,257.65	1,271.31	1,139.44
Total Assets	7,012.45	5,851.59	5,607.95	7,689.63	7,665.29	7,360.17
Total Debt*	2,990.75	3,704.08	2,704.34	4,524.54	5,156.70	4,762.18
Net Current Assets	141.73	40.79	42.13	9.18	116.16	-133.64

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Cash From Operating Activities	--	346.47	517.86	582.06	284.83	401.23
Cash Flow from Investing Activities	--	-216.49	-231.01	-268.48	-226.34	-256.59
Cash from Financing Activities	--	-163.15	-311.17	-327.48	-34.89	-647.39
Net Cash Inflow / Outflow	--	--	--	--	23.60	-502.75

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Adjusted EPS ($)	1.08	1.18	1.66	1.97	1.25	3.10
Cash EPS ($)	--	2.32	3.24	3.65	2.87	4.66
Adjusted Book Value ($)	--	13.81	13.02	10.40	8.82	8.56
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	2.81	4.01	4.70	2.24	3.09
Free Cash Flow per Share ($)	--	3.10	4.18	2.85	0.74	1.70

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
ROCE (%)	--	2.99	4.20	4.03	2.62	7.04
ROE (%)	3.69	8.63	14.41	20.20	14.25	37.06
ROA (%)	1.96	2.55	3.22	3.17	2.12	5.36
EBIT Margin (%)	6.79	7.16	5.85	8.72	6.78	12.34
Net Margin (%)	2.42	2.68	4.13	3.65	2.50	6.43
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Revenue Growth (%)	29.19	0.05	-0.22	0.05	0.02	0.12
EBIT Growth (%)	160.52	28.66	-47.78	35.21	-43.88	60.31
Net Profit Growth (%)	-32.01	-31.69	-12.10	53.14	-60.47	55.30
EPS Growth (%)	-22.56	-0.29	-0.16	0.57	-0.60	0.56
Book Value Growth (%)	4.36	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Price / Earnings	15.43	12.54	11.38	11.95	19.86	9.48
Price / Book Value	1.17	1.08	1.45	2.26	2.81	3.43
Dividend Yield (%)	1.51	--	--	--	--	--
EV/EBITDA	9.66	10.39	10.01	9.27	12.81	8.78
Close Price ($)	16.29	14.85	18.85	12.66	13.38	15.84
High Price ($)	18.60	20.83	22.08	18.05	16.60	23.49
Low Price ($)	11.65	11.65	12.43	11.47	10.16	13.80
Market Cap ($ Cr)	2,046.30	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debt to Equity	1.05	2.17	1.61	3.51	4.60	4.29
Short term debt to equity ratio	0.13	0.13	0.13	0.21	0.28	0.26
Current Ratio	1.15	1.04	1.04	1.01	1.10	0.90
Quick Ratio	1.15	--	--	0.99	1.17	--
Interest Coverage	3.22	3.32	2.36	2.92	2.54	5.63

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debtors to sales (%)	17.20	15.85	15.84	10.87	14.86	14.33
Asset Turnover	0.81	0.95	0.78	0.87	0.84	0.83
Receivable days	--	56.45	54.41	45.64	52.79	52.57
Inventory Days	--	--	1.82	-1.66	-4.88	0.39
Payable days	--	11.33	11.87	10.85	13.72	14.20
Cash Conversion Cycle	--	--	44.36	33.13	34.19	38.76

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Income Statement ($ Mln)